A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Aijun Chen
First Affiliated Hospital of Chongqing Medical University
Principal Investigator - Chao Ci
First Affiliated Hospital of Wannan Medical College
Principal Investigator - Chao Ji
First Affiliated Hospital of Fujian Medical University
Principal Investigator - Chunlei Zhang
Peking University Third Hospital
Principal Investigator - Chunshui Yu
Suining Central Hospital
Principal Investigator - Fengming Hu
Jiangxi Dermatology Hospital
Principal Investigator - Guoqiang Zhang
The First Hospital of Hebei Medical University
Principal Investigator - Jianguo Li
Henan Provincial People's Hospital
Principal Investigator - Jinhua Xu
Huashan Hospital
Principal Investigator - Linfeng li
Beijing Friendship Hospital
Principal Investigator - Mingkai Ji
Second Affiliated Hospital of Xiamen Medical College
Principal Investigator - Qing Guo
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Principal Investigator - Rixin Chen
Nanyang city first People's Hospital
Principal Investigator - Rong Xiao
The Second Xiangya Hospital, Central South University
Principal Investigator - Shanshan Li
The First Hospital of Jilin University
Principal Investigator - Shifa Zhang
North East Central International Hospital Limited
Principal Investigator - Shiqin Tao
Wuxi No. 2 People's Hospital
Principal Investigator - Songmei Geng
The Second Affiliated Hospital of Xi 'an Jiaotong University
Principal Investigator - Tianhong Xu
The Third People's Hospital of Hangzhou
Principal Investigator - Tiechi Lei
Wuhan University People's Hospital
Principal Investigator - Weili Pan
Zhejiang Provincial People's Hospital
Principal Investigator - Xiaodong Sun
Shenyang Hospital of Integrated Chinese and Western Medicine
Principal Investigator - Xiaohua Wang
Dermatology Hospital of Southern Medical University
Principal Investigator - Xiaojing Kang
Xinjiang Autonomous Region People's Hospital
Principal Investigator - Xiaoyong Zhou
Wuhan First Hospital
Principal Investigator - Xinghua Gao
First Hospital of China Medical University
Principal Investigator - Xinsuo Duan
The Affiliated Hospital of Chengde Medical College
Principal Investigator - Yan Zhou
First Affiliated Hospital Xi'an Jiaotong University
Principal Investigator - Yangfeng Ding
Shanghai Dermatology Hospital
Principal Investigator - Yanyan Feng
Chengdu Second people's hospital
Principal Investigator - Yayu Hu
Taizhou University Affiliated Municipal Hospital
Principal Investigator - Yu Wang
The Affiliated Hospital Of Guizhou Medical University
Principal Investigator - Yuzhen Li
The Second Affiliated Hospital of Harbin Medical University
Principal Investigator - Zhu Shen
Guangdong Provincial People's Hospital
Principal Investigator - Zudong Meng
Shiyan City People's Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Huashan Hospital of Fudan University
Shanghai, Shanghai Municipality, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Sept 2023
- Primary completion
- 31 Jul 2024
- Completion
- 31 Aug 2024
- Last update posted
- 6 Dec 2023
- Registered enrollment
- 120
- Registry id
- NCT06077331
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.